Dr Muhammed Elhadi speaks to ecancer in an online interview for the AACR 2022 meeting about the varying outcomes of paediatric cancer patients in lower-and middle-income countries (LMICs) during the COVID-19 pandemic.

Dr Elhadi starts by discussing the problem they hoped to address, before describing the design of the study. He reports that, as they expected, paediatric cancer patients in LMICS faced significantly higher mortality risk during the pandemic, and he describes some of the factors responsible for this disparity.

Dr Elhadi closes by discussing how these results can be addressed to try and mitigate the effects of the pandemic and tackle healthcare inequalities.